quoinpharma.com - QNRX Market Value

Official company branding of Quoin Pharmaceuticals Ltd. (QNRX)

Quoin Pharmaceuticals (QNRX) dominates the rare skin pathology therapy niche, possessing exceptional pricing power due to a lack of alternatives. This price trend chart, where the market capitalization stands at 0.02, confirms the company's position. The business relies on the development of treatments for Netherton syndrome, holding FDA orphan drug status and successful clinical trial results.

QNRX (Quoin Pharmaceuticals Ltd) Market Capitalization history from 07/04/2022 to 11/16/2026

Comprehensive metric breakdowns and analytics for Quoin Pharmaceuticals Ltd. (QNRX)

- market price and analyst price targets:
Fundamental company analysis:QNRX (Quoin Pharmaceuticals Ltd.)
Product sample of quoinpharma.com

Strategic alliances of Quoin Pharmaceuticals (QNRX) in the field of dermatology are accelerating the commercialization of orphan drugs. The issuer's market capitalization aggregates the value of all shares, reflecting the total business valuation by investors. This chart captures the equilibrium points of supply and demand within the sector. Value consolidation confirms the company's fundamental stability as it prepares for new trends. Current indicator volatility determines the brand's investment attractiveness.